Last updated on November 2015

Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY


Brief description of study

Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY

Detailed Study Description

This is a safety and efficacy study of abicipar pegol in patients with neovascular age-related macular degeneration.

Clinical Study Identifier: TX141989

Find a site near you

Start Over